−2.07USD
−114.53 MUSD
8.95 MUSD
13.23 M
About Affimed N.V.
Sector
Industry
CEO
Andreas Harstrick
Website
Headquarters
Mannheim
Employees (FY)
78
Founded
2000
ISIN
NL0015001ZQ0
FIGI
BBG006R5SSH5
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AFMD is 5.07 USD — it has decreased by 3.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Affimed N.V. stocks are traded under the ticker AFMD.
Affimed N.V. is going to release the next earnings report on May 22, 2024. Keep track of upcoming events with our Earnings Calendar.
AFMD stock is 4.34% volatile and has beta coefficient of 2.41. Check out the list of the most volatile stocks — is Affimed N.V. there?
One year price forecast for Affimed N.V. has a max estimate of 24.64 USD and a min estimate of 4.93 USD.
AFMD earnings for the last quarter are −1.69 USD whereas the estimation was −1.95 USD which accounts for 13.16% surprise. Estimated earnings for the next quarter are −1.70 USD. See more details about Affimed N.V. earnings.
Affimed N.V. revenue for the last quarter amounts to 2.07 M USD despite the estimated figure of 1.93 M USD. In the next quarter revenue is expected to reach 1.66 M USD.
Yes, you can track Affimed N.V. financials in yearly and quarterly reports right on TradingView.
AFMD stock has fallen by 13.92% compared to the previous week, the month change is a 11.43% rise, over the last year Affimed N.V. has showed a 36.63% decrease.
AFMD net income for the last quarter is −21.73 M USD, while the quarter before that showed −26.49 M USD of net income which accounts for 17.99% change. Track more Affimed N.V. financial stats to get the full picture.
Today Affimed N.V. has the market capitalization of 79.64 M, it has decreased by 1.71% over the last week.
No, AFMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AFMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Affimed N.V. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 78.00 employees. See our rating of the largest employees — is Affimed N.V. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Affimed N.V. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Affimed N.V. stock shows the sell signal. See more of Affimed N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Affimed N.V. future price: according to them, AFMD price has a max estimate of 24.64 USD and a min estimate of 4.93 USD. Read a more detailed Affimed N.V. forecast: see what analysts think of Affimed N.V. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Affimed N.V. EBITDA is −118.48 M USD, and current EBITDA margin is −1.32 K%. See more stats in Affimed N.V. financial statements.